Literature DB >> 23128975

Hypersensitivity reaction to intravenous but not oral tacrolimus.

Sarah Nicolai, Supinda Bunyavanich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23128975      PMCID： PMC3491576          DOI： 10.1097/TP.0b013e31826e5995

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

Review 1.  Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.

Authors:  Janos Szebeni
Journal:  Toxicology       Date:  2005-09-02       Impact factor: 4.221

2.  Polyoxyl 60 hydrogenated castor oil free nanosomal formulation of immunosuppressant Tacrolimus: pharmacokinetics, safety, and tolerability in rodents and humans.

Authors:  Shoukath M Ali; Ateeq Ahmad; Saifuddin Sheikh; Moghis U Ahmad; Rajendar C Rane; Prashant Kale; Mahesh Paithankar; Dipak Saptarishi; Ashish Sehgal; Kirti Maheshwari; Imran Ahmad
Journal:  Int Immunopharmacol       Date:  2009-12-21       Impact factor: 4.932

3.  Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient.

Authors:  Y Takamatsu; M Ishizu; I Ichinose; K Ogata; M Onoue; M Kumagawa; J Suzumiya; K Tamura
Journal:  Bone Marrow Transplant       Date:  2001-08       Impact factor: 5.483

4.  IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine.

Authors:  D G Ebo; G C Piel; V Conraads; W J Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2001-09       Impact factor: 6.347

Review 5.  Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.

Authors:  G W Volcheck; R G Van Dellen
Journal:  Ann Allergy Asthma Immunol       Date:  1998-02       Impact factor: 6.347

6.  Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel.

Authors:  Amanda N Fader; Peter G Rose
Journal:  Int J Gynecol Cancer       Date:  2009-10       Impact factor: 3.437

7.  The effects of cremophor EL in the anaesthetized dog.

Authors:  J H Gaudy; J F Sicard; F Lhoste; J F Boitier
Journal:  Can J Anaesth       Date:  1987-03       Impact factor: 5.063
  7 in total
  5 in total

1.  Rectal and sublingual administration of tacrolimus: a single-dose pharmacokinetic study in healthy volunteers.

Authors:  Frank Stifft; Floris Vanmolkot; Ingrid Scheffers; Luc van Bortel; Cees Neef; Maarten Christiaans
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

2.  A pediatric patient with intravenous cyclosporine anaphylaxis who tolerated the oral form.

Authors:  Pamir Işık; Namik Özbek; Emine Dibek Mısırlıoğlu; Turan Bayhan; Suna Emir; Fatih Mehmet Azık; Bahattin Tunç
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

3.  Development and characterization of methoxy poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) micelles as vehicles for the solubilization and delivery of tacrolimus.

Authors:  Raisuddin Ali; Abubakar Farah; Ziyad Binkhathlan
Journal:  Saudi Pharm J       Date:  2016-07-01       Impact factor: 4.330

4.  Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity.

Authors:  Aws Alshamsan; Ziyad Binkhathlan; Mohd Abul Kalam; Wajhul Qamar; Hala Kfouri; Mohammed Alghonaim; Afsaneh Lavasanifar
Journal:  Sci Rep       Date:  2020-04-21       Impact factor: 4.379

5.  Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next?

Authors:  Sung-Yoon Kang; Kyoung-Hee Sohn; Jeong-Ok Lee; Sae-Hoon Kim; Sang-Heon Cho; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2015-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.